Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

被引：0
|
作者：
Ran Li
Hongge Liang
Jun Li
Zhenyu Shao
Donghong Yang
Jing Bao
Keqiang Wang
Wen Xi
Zhancheng Gao
Renhua Guo
Xinlin Mu
机构：
[1] Peking University People’s Hospital,Department of Respiratory and Critical Care Medicine, Lung Cancer Center
[2] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[3] Qilu Hospital of Shandong University,Department of Radiation Oncology
来源：
BMC Cancer | / 24卷
关键词：
Paclitaxel liposome; Immunotherapy; Immune checkpoint inhibitor; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] First-line treatment patterns and outcomes in advanced non-small cell lung cancer in Sweden: a population-based real-world study with focus on immunotherapy
    Wagenius, Gunnar
    Vikstrom, Anders
    Berglund, Anders
    Salomonsson, Stina
    Bencina, Goran
    Hu, Xiaohan
    Chirovsky, Diana
    Brunnstrom, Hans
    ACTA ONCOLOGICA, 2024, 63 : 198 - 205
  • [42] Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
    Wu, Yijun
    Yao, Zhuoran
    Zhang, Jianhui
    Han, Chang
    Kang, Kai
    Zhao, Ailin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
    Shen, Jie
    Gu, Linping
    Qi, Yuwen
    Yao, Yaxian
    Lu, Shun
    Chen, Zhiwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study
    Hu, Jia
    Huang, Di
    Wang, Yanrong
    Li, Donghui
    Yang, Xuejiao
    Fu, Yan
    Du, Nan
    Zhao, Yan
    Li, Xiaosong
    Ma, Junxun
    Hu, Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] A real-world study in advanced non-small cell lung cancer with de novo brain metastasis
    Lei, Lei
    Wang, Wen-xian
    Wang, Dong
    Lin, Li
    Zhu, You-cai
    Wang, Hong
    Wang, Li-ping
    Zhuang, Wu
    Fang, Mei-yu
    Wan, Bing
    Feng, Hui-jing
    Xu, Chun-wei
    JOURNAL OF CANCER, 2021, 12 (05): : 1467 - 1473
  • [46] Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Sun, Lei
    Zhao, Qi
    Wang, Yanning
    Wang, Yongsheng
    Zheng, Ming
    Ding, Xuansheng
    Miao, Liyun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4165 - 4179
  • [47] Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
    Smeenk, Michiel M.
    van der Noort, Vincent
    Hendrikx, Jeroen M. A.
    Kalkhoran, Hanieh Abedian
    Smit, Egbert F.
    Theelen, Willemijn S. M. E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [48] Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study
    Zhang, Meiling
    Wang, Li
    Wang, Qian
    Yang, Jiu
    Peng, Wei
    Li, Xiaoyou
    Shi, Meiqi
    Lu, Kaihua
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [49] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Fränce Hardtstock
    David Myers
    Tracy Li
    Diana Cizova
    Ulf Maywald
    Thomas Wilke
    Frank Griesinger
    BMC Cancer, 20
  • [50] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Hardtstock, Fraence
    Myers, David
    Li, Tracy
    Cizova, Diana
    Maywald, Ulf
    Wilke, Thomas
    Griesinger, Frank
    BMC CANCER, 2020, 20 (01)
12345